FGFR2 and Apert syndrome: Also, Miraoui et al demonstrated that ERK activation is involved in the osteogenic differentiation of mesenchymal stem cells carrying the S252W mutation in fibroblast growth factor receptor 2 (FGFR2) associated with Apert syndrome, a rare congenital disorder characterized by craniosynostosis.51